Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus
Present therapies to minify hyperglycaemia and insulin resistance mainly target ATP-sensitive K+ channels (KATP) of pancreatic cells and PPAR-γ to enhance the insulin secretion and potential for GLUT expression, respectively. These current approaches are frequently associated with the various side e...
Saved in:
Main Authors: | Danish Ahmed, Manju Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2011/530274 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder
by: Syouichi Katayama, et al.
Published: (2020-01-01) -
Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase
by: Ahmed Mahmood, et al.
Published: (2017-09-01) -
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
by: Ilenia Pellarin, et al.
Published: (2025-01-01) -
Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products
by: Abhijit Debnath, et al.
Published: (2025-01-01) -
Influence of ethnicity on cyclin-dependent kinase inhibitor efficacy and toxicity: A systematic review and meta-analysis
by: Roberto Buonaiuto, et al.
Published: (2025-02-01)